Title : [Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers].

Pub. Date : 2015 Apr

PMID : 25790739






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Trastuzumab emtansine, consisting of trastuzumab coupled to a cytotoxic agent, emtansine (DM1), by a stable linker, has been approved in November 2013 by the European Medicine Agency. t-dm1 immunoglobulin heavy diversity 1-7 Homo sapiens